Wade Walke | VP, IR |
Stanley Crooke | Chairman and CEO |
Elizabeth Hougen | CFO |
Brett Monia | COO |
Damien McDevitt | Chief Business Officer |
Tyler Van Buren | Piper Jaffray |
Jim Birchenough | Wells Fargo |
Chad Messer | Needham & Company |
Ritu Baral | Cowen & Company |
Yale Jen | Laidlaw & Company |
David Lebowitz | Morgan Stanley |
Jessica Fye | JP Morgan |
Good morning, and welcome to Ionis Pharmaceuticals Second Quarter 2019 Financial Results Conference Call.
As a reminder, this call is being recorded.
At this time, I would like to turn the call over to Wade Walke, Vice President of Investor Relations, to lead off the call. Please begin.
Thank you, Nicole.